¢º
À¯Áø»çÀ̾𽺠´ëÇ¥ÀÌ»ç Àλ縻_About EugeneScience CEO
     
  À¯Áø»çÀ̾𽺴 ½Ä»ýȰÀÌ Ç³¿ä·Î¿öÁö°í À°Ã¼³ëµ¿ÀÌ  
  ÁÙ¾îµå´Â ¿À´Ã³¯, Çö´ëÀε鿡°Ô °¡Àå ¸¹ÀÌ ¹ß»ýÇÏ´Â  
  Áúº´À» ½Äǰ°ú ÀǾàǰÀÇ °æ°è¸¦ Çã¹°¾î ÀÏ»ó »ýȰ ¼Ó¿¡¼­  
  º¸´Ù Æí¸®ÇÏ°í ¾ÈÁ¤ÀûÀÎ ¹æ¹ýÀ¸·Î Ä¡·áÇÒ ¼ö ÀÖµµ·Ï ±â¼ú  
  °³¹ß¿¡ ¸ÅÁøÇϰí ÀÖ½À´Ï´Ù.  
     
  ´ç»ç°¡ °³¹ßÇÑ ÄÝ·¹½ºÅ×·Ñ ÀúÇϹ°Áú À¯ÄÝÀ» Àû¿ëÇÑ À½·á  
  "ÄÝ·¹½ºÅ×·Ñ ÇÁ·Î±×·¥ ÄÝÁ¦·Î"¸¦ ź»ý½ÃŲ ±â¼ú·Â°ú źźÇÑ  
  ¼öÀ͸ðµ¨À» ¹ÙÅÁÀ¸·Î ÇâÈÄ¿¡´Â ÇÑ ¹æ¿ïÀÇ ÇÇ·Î ¼ºÀκ´À»  
  ¿¹ÃøÇÏ°í °³°³ÀÎÀÇ Æ¯¼º¿¡ µû¶ó ½Äǰ, ¾àǰ, À¯ÀüÀÚ Á¶ÀýÀ»  
  ÅëÇØ Áúº´À» ¸ÂÃã Ä¡·áÇÏ´Â Pharmacogenomics Àü¹®±â¾÷À¸
 
  ·Î¼­ Àηù °Ç°­À» ÁöŰ´Â Ãæ½ÇÇÑ ÆÄ¼ö²ÛÀÌ µÇ°Ú½À´Ï´Ù.  
     
 
  ƯÈ÷ ÄÝ·¹½ºÅ×·Ñ, ºñ¸¸, ´ç´¢ µî 3´ë ¼ºÀκ´ÀÇ Ä¡·á¿Í ¿¹¹æÀ» À§ÇÑ ¿¬±¸°³¹ß¿¡ Çٽɿª·®À»
  ÁýÁß½Ã۰í ÀÖÀ¸¸ç, À̸¦ ÅëÇØ °Ç°­°ú dz¿äÀÇ °úÇÐÀ̶ó´Â ±â¾÷À̳äÀ» ½ÇÇö½ÃÄÑ ³ª°¥°ÍÀÔ´Ï´Ù.
 
  ¢º " À¯Áø»çÀ̾𽺴 °Ç°­°ú dz¿äÀÇ °úÇÐÀ» ½ÇÇöÇÏ´Â ±â¾÷ÀÌ µÇ°íÀÚ ÇÕ´Ï´Ù. ¼ºÀκ´ Àü¹®±â¾÷
  À¸·Î ¹ßÀüÇÒ »Ó¸¸ ¾Æ´Ï¶ó ÀúÈñµéÀÌ °®°í ÀÖ´Â °úÇÐ ±â¼ú ¿ª·®ÀÌ °æÁ¦ÀûÀ¸·Î ¼Ò¿ÜµÈ °èÃþ¿¡µµ
  °ñ°í·ç µ¹¾Æ°¥ ¼ö ÀÖ°Ô ÇÏ´Â ±â¾÷ÀÌ µÇ°íÀÚ ÇÕ´Ï´Ù.
   
  ¾ÕÀ¸·Î »ý¸í°øÇлê¾÷Àº ¸¹Àº ¹ßÀüÀ» ÇҰŶó ±â´ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ »ý¸í°øÇлê¾÷ÀÌ Çѱ¹ÀÇ
  ÁÖ·ù»ê¾÷ÀÌ µÇ´Âµ¥ À־ ÀúÈñµéÀÌ ÀÏÁ¤ ºÎºÐ ±â¿©Çϵµ·Ï ÇϰڽÀ´Ï´Ù.
   
  " EugeneScience Inc. strives to become a corporation that uses science to benefit the
  health of humankind. We wish to become a company specializing in drug treatments
  for geriatric diseases and deliver products to financially disadvantaged people.
   
  We believe that the biotechnology industry has a great future and we are channeling our
  efforts into establishing the BT industry as a promising growth industry in Korea.
   
 
- ¾Æ¸®¶ûTV ÀÎÅÍºä ³»¿ëÁß -